Skip to playerSkip to main content
  • 5 years ago
Johnson and Johnson paused the stage 3 trial after a participant developed an unexplained illness as the Lancet confirmed reinfection in a 25-year-old Nevada man without underlying conditions

Category

🗞
News
Comments

Recommended